Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and Management

por Najam, Osman, Ray, Kausik K.
Publicado 2015

Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibi...

por Nishikido, Toshiyuki, Ray, Kausik K.
Publicado 2019

New Approaches in Detection and Treatment of Familial Hypercholesterolemia

por Hartgers, Merel L., Ray, Kausik K., Hovingh, G. Kees
Publicado 2015

‘Highest risk–highest benefit’ strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies

por Annemans, Lieven, Packard, Chris J, Briggs, Andrew, Ray, Kausik K
Publicado 2018

American Heart Association’s Cholesterol CarePlan as a Smartphone-Delivered Web App for Patients Prescribed Cholesterol-Lowering Medication: Protocol for an Observational Feasibili...

por Woringer, Maria, Dharmayat, Kanika I, Greenfield, Geva, Bottle, Alex, Ray, Kausik K
Publicado 2019

Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excell...

por Steen, Dylan L, Khan, Irfan, Ansell, David, Sanchez, Robert J, Ray, Kausik K
Publicado 2017

Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved?: Results from the DA VINCI study

por Siostrzonek, Peter, Brath, Helmut, Zweiker, Robert, Drexel, Heinz, Hoelzl, Robert, Hemetsberger, Margit, Ray, Kausik K.
Publicado 2021

Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans

por Mazidi, Mohsen, Kengne, Andre Pascal, Mikhailidis, Dimitri P., Toth, Peter P., Ray, Kausik K., Banach, Maciej
Publicado 2017

Correction to: Role of Bempedoic Acid in Clinical Practice

por Ballantyne, Christie M., Bays, Harold, Catapano, Alberico L., Goldberg, Anne, Ray, Kausik K., Saseen, Joseph J.
Publicado 2021

Role of Bempedoic Acid in Clinical Practice

por Ballantyne, Christie M., Bays, Harold, Catapano, Alberico L., Goldberg, Anne, Ray, Kausik K., Saseen, Joseph J.
Publicado 2021

Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid

por Ballantyne, Christie M., Bays, Harold E., Louie, Michael J., Smart, Jeremy, Zhang, Yang, Ray, Kausik K.
Publicado 2022

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER...

por Ference, Brian A, Cannon, Christopher P, Landmesser, Ulf, Lüscher, Thomas F, Catapano, Alberico L, Ray, Kausik K
Publicado 2018

Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations

por Orringer, Carl E., Tokgozoglu, Lale, Maki, Kevin C., Ray, Kausik K., Saseen, Joseph J., Catapano, Alberico L.
Publicado 2020

Time‐Dependent Cardiovascular Treatment Benefit Model for Lipid‐Lowering Therapies

por Khan, Irfan, Peterson, Eric D., Cannon, Christopher P., Sedita, Lauren E., Edelberg, Jay M., Ray, Kausik K.
Publicado 2020

Low-density lipoprotein cholesterol goal attainment in Germany: Results from the DA VINCI study

por Gouni-Berthold, Ioanna, Schaper, Frank, Schatz, Ulrike, Tabbert-Zitzler, Anja, Fraass, Uwe, Sauer, Sarah, Ray, Kausik K.
Publicado 2022

Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?

por Makris, Anastasios, Barkas, Fotios, Sfikakis, Petros P., Liberopoulos, Evangelos, Filippatos, Theodosios D., Ray, Kausik K., Agouridis, Aris P.
Publicado 2023

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics

por Boden, William E, Bhatt, Deepak L, Toth, Peter P, Ray, Kausik K, Chapman, M John, Lüscher, Thomas F
Publicado 2020

Estimated cardiovascular benefits of bempedoic acid in patients with established cardiovascular disease

por Gunn, Laura H., McKay, Ailsa J., Feng, Amy, Louie, Michael J., Ballantyne, Christie M., Ray, Kausik K.
Publicado 2022

Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA...

por Brandts, Julia, Bray, Sarah, Villa, Guillermo, Catapano, Alberico L., Poulter, Neil R., Vallejo-Vaz, Antonio J., Ray, Kausik K.
Publicado 2023

Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study

por Danese, Mark D, Gleeson, Michelle, Kutikova, Lucie, Griffiths, Robert I, Khunti, Kamlesh, Seshasai, Sreenivasa Rao Kondapally, Ray, Kausik K
Publicado 2017